On November 14, the "Intelligent Medicine Future, Innovation and Brilliance"-"Voice of Oriole" 2025 Pharmaceutical Engineering Technology Exchange Conference (Suzhou Station) sponsored by the National Pharmaceutical Engineering was successfully held. This conference attracted more than 100 pharmaceutical companies in East China and more than 400 pharmaceutical industry experts to participate in the conference to carry out in-depth exchanges and discussions on core topics such as cutting-edge technology and development trends of pharmaceutical engineering.

In his opening speech, Chen Jinhui, Secretary of the Party Committee and Director of Sinopharm Engineering, pointed out that at present, the global pharmaceutical industry is undergoing a dual transformation of biotechnology breakthroughs and intelligent manufacturing upgrades, and the post-epidemic era also puts forward higher requirements for supply chain resilience, with both opportunities and challenges for the industry. He said that this year is the final year of the "14th Five-Year Plan" and the year of the layout of the "15th Five-Year Plan". The Sinoparma Project will focus on the direction of "intelligent environmental transportation" and use engineering technology, product equipment and digital intelligence. As the core, continue to promote the upgrading of traditional industries and the integrated application of new technologies. On the basis of consolidating the general contracting service capabilities of industrial engineering, the company will build the technical service capabilities of the entire pharmaceutical and health industry chain, and strive to become a trusted and industry-leading professional engineering and technical service provider, and draw a beautiful blueprint for a healthy China. This exchange meeting is an important platform to gather industry wisdom and jointly explore the path of high-quality development in the new era, which will help pharmaceutical engineering to move steadily towards intelligent and green direction.

Liu Yuan, a master of engineering design in petrochemical and pharmaceutical industry, took "Concurrent and Symbiosis: Practical Framework and Industry Enlightenment of Intelligent Medicine Two-state Engineering" as the title, combined with several key project cases, systematically analyzed the remarkable achievements of the project in shortening the construction cycle and reducing the operating cost, and provided a set of highly operable implementation path and landing experience for enterprises.

Ye Ping, chief technical expert of the National Pharmaceutical Engineering and member of the master studio, carried out professional sharing around the "Continuous Manufacturing Solution for Preparations", elaborated in depth the core principles, application scenarios and efficiency advantages of the technology, and provided professional reference for pharmaceutical enterprises to promote process upgrading.

During the exchange meeting, the participating experts also conducted multi-dimensional discussions on hot topics such as the application of new technologies in pharmaceutical factories, the construction management of overseas bases, and the practice of digital construction. The interaction on the scene was enthusiastic and the exchange of views was frequent. Representatives of many enterprises said that the meeting not only provided cutting-edge technical vision and reusable practical experience, but also promoted the effective docking of resources within the industry, laying a solid foundation for future cooperation.

This exchange meeting not only built an efficient technical exchange and knowledge sharing platform for professionals in the field of pharmaceutical engineering, but also injected strong impetus into the sustainable development of the pharmaceutical engineering industry. Sinopharm will continue to play the role of industry innovation engine, actively build a new industrial ecology of open cooperation, and inject new momentum into accelerating the intelligent upgrading and global layout of the pharmaceutical industry.

(Shanghai Company Contribution)